A legally authorized representative (LAR) is an individual, or in some legal frameworks a judicial or other body, authorized to make specified decisions on another person’s behalf. The term is especially important in human-subject research, where a representative may provide informed consent for a prospective participant who cannot legally provide it personally. The representative’s authority depends on the applicable law, the decision involved, and any limits imposed by a statute, appointment, or governing document. It is not a universal status carrying unrestricted power over another person’s affairs.
Meaning and scope
A legally authorized representative acts within a defined scope of authority. Authorization to make financial decisions does not necessarily include healthcare decisions, and authorization to consent to medical treatment does not automatically include participation in research.
Depending on the jurisdiction, authority may arise from:
- A court order appointing a guardian or another decision-maker.
- A valid power of attorney that covers the relevant decisions.
- A statute identifying eligible surrogate decision-makers and, sometimes, their order of priority.
- A parental or guardianship relationship, subject to rules governing decisions for children.
- A regulatory provision recognizing a representative for a particular purpose.
An advance directive may identify a decision-maker, record instructions, or do both, depending on its form and governing law. Neither a family relationship nor designation as an emergency contact necessarily establishes authority to consent to research.
“Legally authorized representative,” “legal representative,” “healthcare proxy,” and “surrogate decision-maker” are therefore related but not invariably interchangeable terms.
Role in United States research regulation
In the United States, the term has a specific role in federal protections for research participants.
Common Rule
The Common Rule, at 45 CFR 46.102(i), defines a legally authorized representative as an individual or judicial or other body authorized under applicable law to consent on behalf of a prospective subject to participation in the procedures involved in the research.
The definition also addresses situations in which no applicable law covers the issue. In those circumstances, it recognizes an individual accepted under institutional policy as appropriate to provide consent in the nonresearch context on behalf of the prospective subject for the procedures involved in the research.
This fallback is limited: it is not a general authorization for an institution to select any convenient person. The institutional policy must concern an appropriate representative for the relevant procedures in a nonresearch setting.
Food and Drug Administration regulations
The Food and Drug Administration’s definition, at 21 CFR 50.3(l), likewise refers to an individual or judicial or other body authorized under applicable law to consent on behalf of a prospective subject to participation in the procedures involved in the research. It does not contain the Common Rule’s express institutional-policy fallback.
Research may be subject to both regulatory systems. Consequently, a representative recognized for one regulatory purpose is not necessarily sufficient for every study.
Ethics review and consent
An institutional review board reviews the proposed protections and consent arrangements for research within its remit. Its approval does not itself confer legal authority on a proposed representative.
Consent by an LAR ordinarily requires an informed-consent process, not merely a signature. The representative receives relevant information about the study, including its purpose, procedures, reasonably foreseeable risks, potential benefits, and alternatives, as required by the applicable rules. Representative consent does not replace other requirements governing whether the research may proceed.
Decision-making ability and legal authority
The need for representation involves two related but distinct questions:
- Can the person understand and make the particular decision?
- Who, if anyone, has legal authority to decide on that person’s behalf?
Decision-making ability is decision-specific and may change over time. Difficulty communicating, a diagnosis, advanced age, or disability does not by itself establish inability to decide. Legal capacity concerns a person’s legally recognized ability to hold or exercise rights; it should not be treated as identical to a clinical assessment of decision-making ability.
A person may be able to make some decisions while needing assistance with others. Where a participant becomes able to provide legally effective consent during a study, continued participation generally requires the participant’s own consent unless an applicable exception or waiver permits otherwise.
Standards and safeguards
Applicable law may require a representative to follow the person’s known instructions and preferences, apply a substituted-judgment standard, or decide according to a best-interests standard. These standards differ: substituted judgment concerns what the person would have chosen, whereas best interests concerns the person’s welfare under the governing legal criteria.
Research presents additional limits because its primary purpose is to produce knowledge, and participation may offer no direct benefit. Representative consent alone does not establish that a study’s risks or inclusion criteria are ethically or legally acceptable.
Safeguards may include verification of the representative’s identity and authority, documentation of its scope, assessment of conflicts of interest, and attention to the participant’s expressed wishes. A participant’s objection or resistance remains relevant even when a representative has consented; its legal effect depends on the governing rules and circumstances.
For children, United States research regulations generally distinguish parental permission from the child’s assent, meaning affirmative agreement to participate. Special protections for children are not displaced simply by identifying an adult representative.
Distinction from other representative roles
An LAR is not necessarily a lawyer, and a lawyer does not automatically possess authority to consent to a client’s treatment or research participation. Similarly, an interpreter, witness, caregiver, or support person may assist communication without holding decision-making authority.
Authority to consent also differs from authority to access records. For example, the HIPAA Privacy Rule uses the separate concept of a personal representative for specified health-information purposes. Overlap is possible, but research consent and authorization concerning health information remain distinct legal questions.
Outside the United States, terminology and powers vary. Cross-border research must therefore determine representation under the law and regulatory framework applicable to each setting rather than assume that recognition in one jurisdiction transfers automatically to another.